Daniel Dix

921 citations

17 papers · 603 indexed · 1 hit paper · h-index 8

Impact in

Cancer Research top 5%
- Cancer Genomics and Diagnostics
Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment

Papers in ⓘ

Cancer Research 8
- Cancer Genomics and Diagnostics 8
Pulmonary and Respiratory Medicine 7
- Lung Cancer Treatments and Mutations 5

Co-authors: Richard B. Lanman (4 shared papers)Karen L. Reckamp (3 shared papers)Davey B. Daniel (3 shared papers)Vassiliki A. Papadimitrakopoulou (3 shared papers)Ray D. Page (3 shared papers)Natasha B. Leighl (3 shared papers)Miguel A. Villalona‐Calero (3 shared papers)Victoria M. Raymond (4 shared papers)
Journals: Journal of Clinical Oncology (2 papers)Journal of Pharmaceutical Sciences (1 paper)Clinical Cancer Research (1 paper)Journal of Healthcare Management (1 paper)Journal of Thoracic Oncology (1 paper)
Partner nations: United States Spain Canada

In The Last Decade

Daniel Dix

17 papers receiving 590 citations

Hit Papers

align trajectories log scale

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer 2019 · 408 citations

Peers

Countries citing papers authored by Daniel Dix

Since Specialization

Citations

This map shows the geographic impact of Daniel Dix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Dix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Dix more than expected).

Fields of papers citing papers by Daniel Dix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Dix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Dix. The network helps show where Daniel Dix may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Dix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Dix Line = papers co-authored together Daniel Dix links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer Clinical Cancer Research ·Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona‐Calero, Daniel Dix, Justin I. Odegaard, Richard B. Lanman, Vassiliki A. Papadimitrakopoulou Hit paper breakdown →	2019	408
2	Weight gain prevention among black women in the rural community health center setting: The Shape Program BMC Public Health ·Perry Foley, Erica Levine, Sandy Askew, Elaine Puleo, Jessica A. Whiteley, Bryan C. Batch, Daniel P. Heil, Daniel Dix, Veronica Lett, Michele G. Lanpher, Jade L. Miller, Karen M. Emmons, Gary G. Bennett	2012	41
3	Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non–Small-Cell Lung Cancer JCO Precision Oncology ·Ramón Palmero, Álvaro Taus, Santiago Viteri, Margarita Majem, Enric Carcereny, J. Garde, Enriqueta Felip, Ernest Nadal, Andrea Malfettone, Miguel Sampayo, François Riva, Rebecca J. Nagy, Richard B. Lanman, Iris Faull, Daniel Dix, Niki Karachaliou, Rafael Rosell	2021	38
4	Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non–Small Cell Lung Cancer Clinical Lung Cancer ·Ray D. Page, Leylah Drusbosky, Hiba I. Dada, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona‐Calero, Daniel Dix, Justin I. Odegaard, Richard B. Lanman, Vassiliki A. Papadimitrakopoulou, Natasha B. Leighl	2021	31
5	Comparative Analysis of Short-Term Postoperative Complications in Outpatient Versus Inpatient Total Ankle Arthroplasty: A Database Study The Journal of Foot & Ankle Surgery ·Chandler Tedder, Henry DeBell, Daniel Dix, Walter R. Smith, Gerald McGwin, Ashish Shah, Sameer Naranje	2018	20
6	The Effects of Protein Stabilizers on Aggregation Induced by Multiple-Stresses YAKUGAKU ZASSHI ·Tsutomu Arakawa, Daniel Dix, Byeong S. Chang	2003	17
7	Correlation of Appointment Times and Subspecialty With the No-Show Rates in an Orthopedic Ambulatory Clinic Journal of Healthcare Management ·Sung R. Lee, Daniel Dix, Gerald McGwin, Christopher K. Odom, César de César Netto, Sameer Naranje, Ashish Shah	2018	13
8	Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery Bioengineering & Translational Medicine ·Erica Schlesinger, Daniel A. Bernards, Hunter H. Chen, James Feindt, Jingtai Cao, Daniel Dix, Carmelo Romano, Robert B. Bhisitkul, Tejal A. Desai	2018	11
9	A systematic review and meta-analysis of complications in conversion arthroplasty methods for failed intertrochanteric fracture fixation Journal of Clinical Orthopaedics and Trauma ·Daniel Dix, Ibukunoluwa Araoye, Jackson R. Staggers, Chee Paul Lin, Ashish Shah, Amit Kumar Agarwal, Sameer Naranje	2018	6
10	How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer? Urology ·Daniel Dix, Andrew M. McDonald, Jennifer Gordetsky, Jeffrey W. Nix, John V. Thomas, Soroush Rais‐Bahrami	2018	5
11	An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies Journal of Pharmaceutical Sciences ·Sorina Morar-Mitrica, Monica L. Adams, George Crotts, Christine Wurth, Peter M. Ihnat, Tanvir Tabish, Valentyn Antochshuk, Willow R. DiLuzio, Daniel Dix, Jason E. Fernandez, Kapil Gupta, Michael S. Fleming, Bing He, James K. Kranz, Dingjiang Liu, Chakravarthy Narasimhan, Eric Routhier, Katherine Taylor, Nobel Truong, Elaine S. E. Stokes	2017	4
12	Abstract 4460: Clinical utility of comprehensive cell-free DNA (cfDNA) analysis to identify genomic biomarkers in newly diagnosed metastatic non-small cell lung cancer (mNSCLC) Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona‐Calero, Daniel Dix, Matthew W. Jackson, Justin I. Odegaard, Vassiliki A. Papadimitrakopoulou	2019	3
13	P2.03-02 Cell-Free DNA (cfDNA) Testing in Lung Adenocarcinoma (LUAC) Patients: Spanish Lung Liquid Versus Invasive Biopsy Program (SLLIP) Journal of Thoracic Oncology ·Ramón Palmero, Álvaro Taus, Santiago Viteri, Margarita Majem, Enric Carcereny, J. Garde, Enriqueta Felip, Miguel Sampayo, L. Galvis Gomez, Nuria López, S. Olsen, Mary Jackson, Iris Faull, Daniel Dix, Niki Karachaliou, Rafael Rosell	2018	2
14	Inhibition of Corneal Angiogenesis by Topical Administration of VEGF Trap Investigative Ophthalmology & Visual Science ·Y. Liu, J. Cao, Hang Song, Daniel Dix, Donna Hylton, J.S. Rudge, George D. Yancopoulos, Stanley J. Wiegand	2007	1
15	Homology-directed repair (HDR)-defective lung adenocarcinomas (LUACs) in circulating tumor DNA (ctDNA) Annals of Oncology ·Niki Karachaliou, Martina I. Lefterova, J.F. Draper, (unknown), Imane Chaib, Ramón Palmero, Álvaro Taus, Santiago Viteri, María González Cao, M. Majem Tarruella, Enric Carcereny, Teresa Morán, J. Garde, E. Felip Font, S. Olsen, Mary Jackson, Miguel Sampayo, Iris Faull, Daniel Dix, Rafael Rosell	2018	1
16	Circulating tumor derived cell-free DNA (ctDNA) to predict recurrence of metastatic colorectal cancer (mCRC) following curative intent surgery or radiation: Interim results. Journal of Clinical Oncology ·Mikaela Esquivel, Bryant H. Chee, Brandon Shih, Li Zhang, Carlos U. Corvera, Kenzo Hirose, Eric K. Nakakura, Katherine Van Loon, Victoria M. Raymond, Daniel Dix, Justin I. Odegaard, Chloé E. Atreya	2019	1
17	Tracking plasma KRAS mutations (mu) in lung adenocarcinoma (LUAC) patients (p) and branching evolution. Journal of Clinical Oncology ·Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Richard B. Lanman, Daniel Dix, Iris Faull, Rebecca J. Nagy, N. Ruiz Lopez, Ramón Palmero, Santiago Viteri, Margarita Majem, Álvaro Taus, Enric Carcereny, J. Garde, François Riva, Andrea Malfettone, Miguel Sampayo, Ana Drozdowskyj, Enriqueta Felip, Rafael Rosell	2019	1

About Daniel Dix

Daniel Dix is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Pharmacy, Pathology and Forensic Medicine and Pharmaceutical Science, having authored 17 papers that have together received 603 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (5 papers), Genetic factors in colorectal cancer (3 papers), Protein purification and stability (2 papers), RNA modifications and cancer (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Lymphatic System and Diseases (1 paper) and Glaucoma and retinal disorders (1 paper). The work is most often cited by research in Cancer Research (408 citations), Pulmonary and Respiratory Medicine (381 citations), Oncology (186 citations), Pathology and Forensic Medicine (109 citations) and Molecular Biology (167 citations). Daniel Dix has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Richard B. Lanman, Karen L. Reckamp, Davey B. Daniel, Vassiliki A. Papadimitrakopoulou, Ray D. Page, Natasha B. Leighl, Miguel A. Villalona‐Calero, Victoria M. Raymond, Stephen G. Divers and Justin I. Odegaard. Their work appears in journals such as Journal of Clinical Oncology, Journal of Pharmaceutical Sciences, Clinical Cancer Research, Journal of Healthcare Management and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact